Suppr超能文献

乳腺癌中的血管侵犯:近期预后进展及分子病理生理机制概述

Vascular invasion in breast cancer; an overview of recent prognostic developments and molecular pathophysiological mechanisms.

作者信息

Mohammed R A A, Ellis I O, Lee A H S, Martin S G

机构信息

Clinical Oncology, University of Nottingham, University Hospitals, Nottingham, UK.

出版信息

Histopathology. 2009 Jul;55(1):1-9. doi: 10.1111/j.1365-2559.2008.03169.x.

Abstract

Vascular invasion (VI) is an essential step in breast cancer metastasis and the main cause of morbidity and mortality from the disease. Detection of VI in the primary tumour is a marker of metastatic potential. The prognostic value of VI in breast cancer has been known for more than four decades, but its application in clinical practice is still fraught with difficulties due to the limited number of studies conducted on large numbers of well-characterized patients with long-term follow-up. Detection of VI in the primary tumour is currently assessed using sections stained with haematoxylin and eosin, which has some disadvantages. A number of vascular markers have been used to improve detection of VI; however, their sensitivity and specificity, as endothelial markers, vary considerably. In this review we describe the evolution of the prognostic importance of VI and the recent pathomolecular mechanisms that contribute to the ability of breast cancers to invade through vessels, in addition to the types, locations and methods of detection of vascular invasion.

摘要

血管侵犯(VI)是乳腺癌转移的关键步骤,也是该疾病发病和死亡的主要原因。原发性肿瘤中血管侵犯的检测是转移潜能的一个标志物。血管侵犯在乳腺癌中的预后价值已被知晓四十多年,但由于针对大量特征明确且有长期随访的患者所开展的研究数量有限,其在临床实践中的应用仍充满困难。目前,原发性肿瘤中血管侵犯的检测是通过苏木精和伊红染色切片进行评估的,这存在一些缺点。已使用多种血管标志物来改善血管侵犯的检测;然而,作为内皮标志物,它们的敏感性和特异性差异很大。在本综述中,我们描述了血管侵犯预后重要性的演变、最近有助于乳腺癌通过血管侵袭能力的病理分子机制,以及血管侵犯的类型、位置和检测方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验